•  
  •  
  •  
  •  

2025-08-28 20:45:43

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
  • HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
  • Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
  • SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
  • Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd

Keywords Selected:  Form483

Stock Report

  • Lupin receives Form 483 with 3 observations from USFDA for Pithampur Unit-3
  • Lupin receives Form 483 with 4 observations from USFDA for Pithampur Unit-2
  • Granules India Ltd receives 1 observation from USFDA for Chantilly facility
  • Unichem Laboratories Ltd receives Form 483 from USFDA with 3 observations for Roha API facility
  • Granules India Ltd receives Form 483 with 1 observation from USFDA for Bonthapally API unit 1
  • U.S. FDA inspection at Glenmark Pharma's Facility at Monroe, North Carolina, USA
  • Sun Pharma gets 8 observations from USFDA for Halol facility
  • Neuland Laboratories Ltd completes USFDA inspection at Unit 2
  • USFDA Inspection at Concord Biotech Ltd's API facility at Dholka
  • J B Chemicals & Pharmaceuticals Ltd successfully completes USFDA inspection at API facility
  • Indoco's Clinical Research Organisation - AnaCipher completes US FDA inspection
  • USFDA Inspection at Unit-1 of Shilpa Pharma Lifesciences Limited
  • USFDA inspection at Emcure Pharmaceuticals Ltd's API facility
  • US FDA Inspection at Piramal Pharma's facility located at Turbhe
  • USFDA inspection at manufacturing facility of Medispray in Kundaim, Goa, India
  • Apitoria Pharma Pvt Ltd gets Form 483 with 10 observations from US FDA
  • Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
  • Aarti Drugs Ltd receives Form 483 with 7 observations from USFDA after inspection at API facility
  • U.S. FDA inspection at Glenmark Pharmaceuticals Ltd's Facility at Chhatrapati Sambhaji Nagar, India
  • Laurus Labs concludes successful USFDA audit for API Manufacturing Facility at Hyderabad
  • Indoco Remedies Ltd gets 7 observations from USFDA for Plant 2 and 3 at Goa
  • Suven Pharmaceuticals Ltd gets Form 483 from USFDA for inspection at Casper Pharma Pvt Ltd
  • Cipla Ltd gets 6 observations from USFDA for Goa facility
  • Torrent Pharmaceuticals Ltd gets Form 483 with 5 observations for Indrad facility

Latest Post

  • Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
  • HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
  • Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
  • SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
  • Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024